We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Builders FirstSource
BLDR
$7.84B
| $661K | 0.01% |
58,626
-286,140
| -83% | -$2.48M |
|
802
Argan
AGX
$7.98B
| $658K | 0.01% |
18,709
-16,710
| -47% | -$524K |
|
803
GoDaddy
GDDY
$12.3B
| $658K | 0.01% |
20,341
-119,141
| -85% | -$3.58M |
|
|
804
Viatris
VTRS
$20.1B
| $657K | 0.01% |
14,177
-1,841,697
| -99% | -$88.9M |
|
|
ERF
805
DELISTED
Enerplus Corporation
ERF
| $639K | 0.01% |
162,543
+58,292
| +56% | +$181K |
|
|
RDC
806
DELISTED
Rowan Companies Plc
RDC
| $638K | 0.01% |
+39,610
| New | +$548K |
|
|
PGND
807
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
| $636K | 0.01% |
21,126
-108,724
| -84% | -$3.09M |
|
|
CSH
808
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $630K | 0.01% |
+16,309
| New | +$532K |
|
|
KKD
809
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $630K | 0.01% |
40,423
-85,813
| -68% | -$1.25M |
|
|
PNRA
810
DELISTED
Panera Bread Co
PNRA
| $624K | 0.01% |
3,047
-10,027
| -77% | -$2M |
|
811
Innospec
IOSP
$2.09B
| $619K | 0.01% |
+14,275
| New | +$660K |
|
|
JUNO
812
DELISTED
Juno Therapeutics, Inc.
JUNO
| $617K | 0.01% |
+16,202
| New | +$565K |
|
|
ESL
813
DELISTED
Esterline Technologies
ESL
| $603K | 0.01% |
9,404
-106,429
| -92% | -$7.01M |
|
|
TIER
814
DELISTED
TIER REIT, Inc.
TIER
| $602K | 0.01% |
+44,808
| New | +$632K |
|
815
BioMarin Pharmaceuticals
BMRN
$11.5B
| $595K | 0.01% |
7,211
-144,237
| -95% | -$11.7M |
|
816
Groupon
GRPN
$980M
| $594K | 0.01% |
+7,440
| New | +$514K |
|
817
Clean Energy Fuels
CLNE
$447M
| $592K | 0.01% |
202,117
+123,572
| +157% | +$347K |
|
|
NXTM
818
DELISTED
NxStage Medical Inc.
NXTM
| $586K | 0.01% |
+39,086
| New | +$655K |
|
819
Brady Corp
BRC
$4.45B
| $583K | 0.01% |
+21,709
| New | +$522K |
|
|
JMEI
820
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $580K | 0.01% |
+8,912
| New | +$575K |
|
821
Green Plains
GPRE
$1.19B
| $579K | 0.01% |
36,252
-233,333
| -87% | -$3.75M |
|
822
Mercury Systems
MRCY
$6.2B
| $576K | 0.01% |
28,356
-77,563
| -73% | -$1.36M |
|
823
Alamo Group
ALG
$2.01B
| $572K | 0.01% |
+10,270
| New | +$545K |
|
|
CAJ
824
DELISTED
Canon, Inc.
CAJ
| $569K | 0.01% |
+19,090
| New | +$549K |
|
825
Moelis & Co
MC
$4.98B
| $565K | 0.01% |
+20,015
| New | +$513K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.